文献速递免疫规划卫生政策与健康促进

比较免疫信息系统、电子病历与自我报告确定2023-2024年美国≥60岁成人RSV疫苗接种状态

Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023-2024.
PubMed 文献 · Vaccine · 2025-11-22

IVY网络前瞻性纳入2023年10月1日至2024年4月30日20州26家医院≥60岁急性呼吸道疾病住院成人,比较免疫信息系统(IIS)、电子病历(EMR)与自我报告确定RSV疫苗接种状态,以三源裁定结果为参照。IIS检出749例中613例(8.5%)接种,自我报告439例(6.1%),EMR334例(4.6%);IIS在强制上报州敏感性92%高于需明确同意州65%(P<0.001)。结论认为IIS检出多于自我报告和EMR,组合多源数据仍是最佳方法。

要点

  • 7219例住院成人中,三源裁定RSV疫苗接种749例(10.4%),IIS检出613例(8.5%),自我报告439例(6.1%),EMR334例(4.6%)。
  • 4422例无缺失数据者中,与裁定结果一致性自我报告κ=0.90最高,IIS κ=0.88次之,EMR κ=0.55最低。
  • 6208例有IIS数据者中,强制纳入州IIS检出敏感性92%高于需明确同意州65%(P<0.001)。

核心结论

  • 多中心分析中,IIS检出的RSV疫苗接种数多于自我报告或EMR,尤其在强制纳入政策的辖区。
  • 组合多个数据源仍是确定美国RSV疫苗接种状态的最佳方法。

研究设计与样本

  • IVY网络前瞻性纳入2023年10月1日至2024年4月30日20州26家医院≥60岁急性呼吸道疾病住院成人。
  • 从辖区IIS、住院EMR和患者(或代理人)访谈获取RSV疫苗接种史,并由三源裁定最终接种状态。
  • 采用未加权Cohen kappa系数、敏感性和特异性比较各来源与裁定状态的一致性。

主要发现

  • 7219例入组患者中,三源裁定RSV疫苗接种749例(10.4%),IIS检出613例(8.5%),自我报告439例(6.1%),EMR检出334例(4.6%)。
  • 自我报告缺失RSV疫苗接种史的比例最高,为30.1%。
  • 4422例无缺失RSV疫苗接种数据者中,与裁定状态一致性自我报告κ=0.90最高,IIS κ=0.88次之,EMR κ=0.55最低。
  • 6208例有IIS数据者中,强制纳入疫苗接种数据州的IIS检出敏感性92%高于需明确同意州65%(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Respiratory syncytial virus (RSV) vaccines were recommended for US adults aged ≥60 years in 2023. Immunization information systems (IISs) are important sources of RSV vaccination data; however, the completeness of documented RSV vaccinations in IISs is unknown. METHODS: The IVY network prospectively enrolled hospitalized adults with acute respiratory illness aged ≥60 years at 26 hospitals in 20 states during October 1, 2023-April 30, 2024. At enrollment, RSV vaccination history was abstracted from jurisdictional IISs, inpatient electronic medical records (EMRs), and through patient (or proxy) interviews with final RSV vaccination status adjudicated from all three sources. Frequencies and proportions of RSV vaccinations identified by IISs, EMRs, and self-report were compared to each other and to adjudicated RSV vaccination status using an unweighted Cohen's kappa coefficient (κ), sensitivity, and specificity. RSV vaccinations documented in IISs were compared by jurisdictional consent policies. Statistical significance was determined using Wilcoxon rank sum or Pearson's chi-squared tests, with a 2-sided P value <0.05. RESULTS: Among 7219 enrolled patients, 749 (10.4 %) had received RSV vaccination adjudicated from all sources, 613 (8.5 %) RSV vaccinations were detected by IISs, 439 (6.1 %) by self-report, and 334 (4.6 %) by EMRs. Self-report had the highest frequency of missing RSV vaccination history (30.1 %). Among 4422 patients with non-missing RSV vaccination data, agreement with adjudicated RSV vaccination status was highest for self-report (κ = 0.90) followed by IISs (κ = 0.88) and EMRs (κ = 0.55). Among 6208 patients with IIS data, the sensitivity of detecting RSV vaccinations was higher in states with mandatory inclusion of vaccination data in IISs than in those that required explicit consent (92 % vs. 65 %, P < 0.001). CONCLUSIONS: In this multicenter analysis, IISs detected more RSV vaccinations than self-report or EMRs, especially in jurisdictions with mandatory inclusion policies. Combining multiple data sources remains the optimal approach to ascertain RSV vaccination status in the US.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Vanasse LT, Safdar B, Self WH, et al. Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023-2024. Vaccine. 2025. PMID: 41275655. doi:10.1016/j.vaccine.2025.127946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。